Screening Novel Molecular Targets of Metformin in Breast Cancer by Proteomic Approach

• Κύριοι συγγραφείς: Lobna Al-Zaidan (Συγγραφέας), Rasha Abu El Ruz (Συγγραφέας), Ahmed M. Malki (Συγγραφέας)
• Μορφή: Βιβλίο
• Έκδοση: Frontiers Media S.A., 2017-10-01T00:00:00Z.
• Θέματα: article
• Διαθέσιμο Online: Connect to this object online.

Metformin is a commonly prescribed antihyperglycemic drug, and has been investigated in vivo and in vitro for its effect to improve the comorbidity of diabetes and various types of cancers. Several studies investigated the therapeutic mechanisms of metformin on cancer cells, but the exact mechanism...